Expression of platelet microparticles in patients with diabetic nephropathy and its relationship with renal damage
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 7
Abstract
Objective To investigate the expression levels of platelet microparticles(PMPs) in patients with diabetic nephropathy (DN) and their relationship with renal injury. Methods Thirty DN patients, 30 T2DM patients without DN and 30 healthy controls were enrolled. Flow cytometry was used to detect the quantity and phenotype of PMPs, and ELISA was used to measure the levels of plasma renin, angiotensin Ⅱ (angiotoninⅡ, AngⅡ), vascular endothelial growth factor (vascular endothelial growth factor, VEGF) and transforming growth factor-β1(transforming growth factor-β1, TGF-β1). Kidney function was determined by blood biochemistry. Results The quantity of PMPs in the DN group was (1 564±346) particles/μL, which was significantly higher than that in the non-DN group (1 246±312) particles/μL and the control group (1 223±299) particles/μL (P<0.05). The PMPs in the DN group mainly expressed CD62P and CD41a, accounting for (76.5±12.3)%. Moreover, the levels and activation of PMPs increased with the progression of DN. The quantity of PMPs was positively correlated with renin and other factors (r=0.56-0.62, P<0.05), negatively correlated with the glomerular filtration rate (GFR) (r=-0.64, P<0.05), and positively correlated with the urinary albumin excretion rate (UAE) (r=0.66, P<0.05). PMPs were also an independent influencing factor of UAE (β=12.34, P<0.05). Conclusion PMPs expression is elevated in DN patients, which may be associated with renal injury, but it is insufficient to confirm its role in the pathogenesis of DN.
Authors and Affiliations
Wen SHAO, Bin DU, Aicui DU, Zhaoqi REN
Keywords
Related Articles
- EP ID EP742813
- DOI 10.13303/j.cjbt.issn.1004-549x.2024.07.010
- Views 37
- Downloads 0
Transfusion adverse events in a tertiary hospital from 2016 to 2022: a retrospective analysis
Objective To strengthen the management of transfusion adverse events, so as to reduce the occurrence of medical damage and accidents, and guarantee the safety of blood transfusion. Methods The adverse events of blood tra...
Platelets inventory changes and supply situation during COVID-19 epidemic
Objective To explore the impact of the COVID-19 epidemic on platelets supply management and its countermeasures. Methods Relevant data on platelets collection, supply, daily inventory and adjustment were collected throug...
Effect of intraoperative cell salvage on allogeneic blood transfusion requirements, coagulation function and electrolytes in postpartum hemorrhage of cesarean section
Objective To explore the effect of intraoperative cell salvage on allogeneic blood transfusion requirements, coagulation function and electrolytes in postpartum hemorrhage patients. Methods A study on postpartum hemorrha...
Explore of nanopore sequencing technology in ambiguities of HLA genotyping
[Objective] To resolve the ambiguities of HLA genotyping generated by next generation sequencing (NGS) using nanopore sequencing technology. [Methods] A total of 38 samples with ambiguous HLA genotyping by NGS in our lab...
Multiple antibodies against -E, -c, -M, and -S: a case report
Objective To identify antibody specificity in an elderly patient with hydronephrosis accompanied by ureteral stones and shock who had multiple antibodies. Methods Microcolumn gel method was used to screen unexpected anti...